Feb. 3, 2025 — Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

March 19, 1514; morning: João de Faria, Portugal’s envoy to the Holy See—the central governing body of the Catholic Church—toiled feverishly over an extraordinary task. Before Rome awoke, the ...